The role of small airway inflammation in asthma

Allergy and Asthma Proceedings

Volumn 23, Issue 4, 2002, Pages 233-242

  Tashkin, Donald P ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIRWAY RESISTANCE; ASTHMA; HUMAN; INFLAMMATION; LUNG; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

AIRWAY RESISTANCE; ASTHMA; HUMANS; INFLAMMATION; LUNG;

EID: 0036634183     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. National Institutes of Health (NIH). Expert panel report 2: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, NIH, 1997.
2. Beasley R, Roche WR, Roberts JA, et al. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 139:806-817, 1989.
3. Holz O, Jorres RA, and Magnussen H. Monitoring central and peripheral airway inflammation in asthma. Respir Med 94(suppl D): S7-S12, 2000.
4. Huber HL, and Koessler K. The pathology of bronchial asthma. Arch Intern Med 30:689-760, 1922.
5. Hogg JC. The pathology of asthma. In Asthma: Physiology, Immunopharmacology and Treatment. Holgate ST, Austen KF, Lichtenstein LM, et al. (Eds). London: Academic Press, 17-25, 1993.
6. Weibel ER Geometry and dimensions of airways conductive and transitory zones. In Morphometry of the Human Lung New York: Academic Press, Inc., 110-135, 1963.
7. Kraft M. The distal airways: are they important in asthma? Eur Respir J 14:1403-1417, 1999.
8. Yanai M, Sekizawa K, Ohrui T. et al. Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol 72:1016-1023, 1992.
9. Ellis JL, Hubbard WC, Meeker S, et al. Ragweed antigen E and anti-IgE in human central versus peripheral isolated bronchi. Am J Respir Crit Care Med 150:717-723, 1994.
10. Mitchell HW, Cvetkovski R, Sparrow MP, et al. Concurrent measurement of smooth muscle shortening, lumen narrowing and flow to acetylcholine in large and small porcine bronchi. Eur Respir J 12: 1053-1061, 1998.
11. Schellenberg RR, Pare PD, Hards J, et al Smooth muscle mechanics: implications for airway hyperresponsiveness. Int Arch Allergy Appl Immunol 94:291-292, 1991.
12. Wagner EM, Bleecker ER, Permutt S. et al. Direct assessment of small airways reactivity in human subjects. Am J Respir Crit Care Med 157:447-452, 1998.
13. Martin C. Uhlig S. and Ullrich V. Videomicroscopy of methacholine-induced contraction of individual airways in precision-cut lung slices. Eur Respir J 9:2479-2487, 1996.
14. Irvin CG, Pak J, and Martin RJ. Airway-parenchyma uncoupling in nocturnal asthma. Am J Respir Crit Care Med 161:50-56, 2000.
15. Kuwano K, Bosken CH, Pare PD, et al. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 148:1220-1225, 1993.
16. James AL, Pare PD. and Hogg JC. The mechanics of airway narrowing in asthma. Am Rev Respir Dis 139:242-246, 1989.
17. Laitinen LA, Laitinen A, and Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 90:32-42, 1992.
18. Carroll N, Elliot J, Morton A, et al The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis 147:405-410, 1993.
19. Hamid Q, Song Y, Kotsimbos TC, et al. Inflammation of small airways in asthma. J Allergy Clin Immunol 100:44-51, 1997.
20. Kraft M, Djukanovic R, Wilson S, et al. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 154:1505-1510, 1996.
21. Taha R, Minshall EM. Miotto D, et al. Eotaxin and monocyte chemotactic protein-4 mRNA expression in small airways of asthmatic and nonasthmatic individuals. J Allergy Clin Immunol 103: 476-483, 1999.
22. Shijubo N, Itoh Y, Yamaguchi T, et al. Clara cell protein-positive epithelial cells are reduced in small airways of asthmatics. Am J Respir Crit Care Med 160:930-933, 1999.
23. Minshall EM, Hogg JC, and Hamid QA. Cytokine mRNA expression in asthma is not restricted to the large airways. J Allergy Clin Immunol 101:386-390, 1998.
24. Martin RJ. Pathophysiology of asthma inflammatory response in small airways and alveolar area. In Asthma and the Small Airways. J Peters SP, Wenzel SE (Eds). New York: American Thoracic Society, 1-6, 2000.
25. Wiggs BR, Bosken C, Pare PD, et al A model of airway narrowing in asthma and in chronic obstructive pulmonary disease Am Rev Respir Dis 145:1251-1258, 1992.
26. Wagner EM, Liu MC, Wcinmann GG, et al. Peripheral lung resistance in normal and asthmatic subjects. Am Rev Respir Dis 141: 584-588, 1990.
27. Woolcock AJ, Vincent NJ. and Macklem PT. Frequency dependence of compliance as a test for obstruction in the small airways J Clin Invest 48:1097-1106, 1969.
28. Goldin JG, Tashkin DP, Kleerup EC, et al Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography. J Allergy Clin Immunol 104: S258-S267, 1999.
29. Tashkin DP, Goldin JG, and Kleerup EC. Evaluation of small airways and the impact of inhaled steroids - size does matter. In Asthma and Small Airways. Peters SP, and Wenzel SE (Eds). New York: American Thoracic Society, 7-15, 2000.
30. Tashkin DP, Trevor E, Chopra SK, et al. Sites of airway dilatation in asthma following inhaled versus subcutaneous terbutaline. Comparison of physiologic tests with radionuclide lung images. Am J Med 68:14-26, 1980.
31. in't Veen JCCM, Beekman AJ, Bel EH, et al. Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes Am J Respir Crit Care Med 161:1902-1906, 2000.
32. McCarthy DS, Spencer R, Greene R, et al. Measurement of "closing volume" as a simple and sensitive test for early detection of small airway disease. Am J Med 52:747-753, 1972.
33. Buist AS, Van Fleet DL, and Ross BB A comparison of conventional spirometric tests and the test of closing volume in an emphysema screening center. Am Rev Respir Dis 107:735-743, 1973.
34. Cosio M, Ghezzo H, Hogg JC, et al. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 298:1277-1281, 1978.
35. Busse WW, and Wenzel SE. Large and small airway dysfunction in asthma: rationale for treating the entire airway. In Asthma and the Small Airways. Peters SP, and Wenzel SE (Eds). New York: American Thoracic Society, 17-23, 2000.
36. Leach CL. Improved delivery of inhaled steroids to the large and small airways. Respir Med 92(suppl A):3-8, 1998.
37. Marshall BG, Wangoo A, Harrison LI, et al. Tumour necrosis factoralpha production in human alveolar macrophages: modulation by inhaled corticosteroid. Eur Respir J 15:764-770, 2000.
38. Davies R, Leach CL, Shaw RJ, et al. Asthma management with HFA-BDP (Qvar). Hosp Med 60:263-270, 1999.
39. Richards J, Hirst P, Pitcairn G, et al Deposition and pharmacokinetics for flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants. J Aerosol Med 14:197-208, 2001.
40. Corren J, Nelson H., Greos L, et al. Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extra fine aerosol in asthma patients. Ann Allergy Asthma Immunol 87:405-411, 2001.
41. Busse WW, Brazinsky S, Jacobson K, et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol 104 1215-1222, 1999.
42. Pedersen S. Safety aspects of corticosteroids in children. Eur Respir Rev 4:33-43, 1994.
43. British Thoracic Society. The British Guidelines on Asthma Management.. Thorax 52(suppl 1):1-21, 1997 (1995 review and position statement).
44. Derendorf H, Hochhaus G, Rohatagi S, et al. Pharmacokinetics of triamcinolone acetonide after intravenous, oral, and inhaled administration. J Clin Pharmacol 35:302-305, 1995.
45. Harding SM. The human pharmacology of fluticasone propionate Respir Med 84(suppl A):25-29, 1990.
46. Affrime MB, Kosoglou T, Thonoor CM, et al. Mometasone fuioate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses. Chest 118:1538-1546, 2000.
47. Fuller R, Johnson M, and Bye A. Fluticasone propionate - an update on preclinical and clinical experience. Respir Med 89(suppl A):3-18, 1995.
48. Casale TB, Nelson HS, Corren J, et al. Long-term safety of flunisolide tiydrofluoroalkane metered-dose inhaler in adults and adolescents with asthma, Clin Drug Invest 21:755-764, 2001.
49. Simons FE. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. N Engl J Med 337:1659-1665, 1997
50. Tinkelman DG, Reed CE, Nelson HS, et al. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 92:64-77, 1993.
51. Agertoft L, and Pedersen S, Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 88:373-381, 1994.
52. Gillman SA, Anolik R, Schenkel E, et al. One-year trial on safety and normal linear growth with flunisolide hydrofluoroalkane in children with asthma. Clin Pediatr 41:333-340, 2002.
53. Brown PH, Blundell G, Greening AP, et al. Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids? Thorax 45:736-739, 1990.
54. Farrer M, Francis AJ, and Pearce SJ. Morning serum cortisol concentrations after 2 mg inhaled beclomethasone dipropionate in normal subjects: effect of a 750 ml spacing device. Thorax 45:740-742, 1990.